FEED the BULL

Welcome to Feed the Bull - A home for investment information and interaction.

Tag: NASDAQ:VTUS

Sort
E.g., 2013-06-19
E.g., 2013-06-19
Enter a comma separated list of user names.

AFOP, ACHN, VTUS, CRWE - CRWEPicks.com Stock Highlights! Alliance Fiber Optic Products, Achillion Pharmaceuticals, Ventrus BioSc
Posted by stockrider on May 16th, 2012

Read More
comment 0
Share
Tags:
Crown Equity Holdings, CRWE, CRWE.OB, NASDAQ:ACHN, achillion, NASDAQ:AFOP, Ventrus Biosciences, Alliance Fiber Optic, NASDAQ:VTUS, CRWE AD-Services

GABC, PEIX, CRWE, VTUS - PennyToBuck.com Stock News! German American Bancorp, Pacific Ethanol, Crown Equity Holdings, Ventrus Bi
Posted by PennyToBuck on May 2nd, 2012

p-b2

Read More
comment 0
Share
Tags:
Crown Equity Holdings, CRWE, CRWE.OB, Pacific Ethanol, Nasdaq:PEIX, Ventrus Biosciences, Nasdaq:GABC, NASDAQ:VTUS, CRWE AD-Services, German American Bancorp

(TISA, CRWE, EMKR, VTUS) StockBling.com Stock Market Activity
Posted by tom on April 30th, 2012

stckbl

chartstockalert

Read More
comment 0
Share
Tags:
Crown Equity Holdings, CRWE, otc:crwe, NASDAQ:TISA, Top Image Systems, EMCORE, Nasdaq:EMKR, Stock Market Activity, Ventrus Biosciences, NASDAQ:VTUS

VTUS, HCA, CRWE, IPCM - CRWEWallStreet.com Stock Highlights! Ventrus Biosciences, HCA Holdings, Crown Equity Holdings, IPC The H
Posted by Johny on March 9th, 2012

Read More
comment 0
Share
Tags:
Crown Equity Holdings, CRWE, CRWE.OB, IPC The Hospitalist Company, NASDAQ:IPCM, IPC The Hospitalist, Ventrus Biosciences, HCA, NYSE:HCA, NASDAQ:VTUS

Ventrus BioSciences (VTUS) - PennyOmega.com Watch List for Monday Nov. 21, 2011
Posted by pennylynnomega on November 20th, 2011

VTUS, Ventrus BioSciences, Inc.

** VTUS reported that it has completed its acquisition of all rights and title to VEN 309 (iferanserin ointment for the topical treatment of symptomatic hemorrhoids) from the licensor, Sam Amer & Co.

Read More
comment 0
Share
Tags:
Ventrus Biosciences, VTUS, NASDAQ:VTUS, gastrointestinal disorders, iferanserin, National Institute of Diabetes and Digestive Kidney Diseases, Sam Amer & Co, symptomatic hemorrhoids, VEN 309

VTUS, CRWE, HCC, DFG, DOW Stock Market Report from CRWEFinance.com
Posted by austinmark on November 20th, 2011

Ventrus BioSciences, Inc. (Nasdaq:VTUS) announced that on November 14, 2011 it completed its acquisition of all rights and title to VEN 309 (iferanserin) from the licensor, Sam Amer & Co.

Read full article at: http://crwefinance.com/21307/stock-alerts/vtus-crwe-hcc-dfg-dow-stock-ma...

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Read More
comment 0
Share
Tags:
VoIP, DOW Chemical, Crown Equity Holdings, NYSE:DOW, NYSE:HCC, NYSE:DFG, Crown Tele Services, Delphi, Ventrus Biosciences, NASDAQ:VTUS, gastrointestinal disorders, iferanserin, sam amr

VTUS, CRWE, HPQ, KBR, BBY Stock Market Update from PennyOtcStock.com
Posted by Steve Stock on November 20th, 2011

Ventrus BioSciences, Inc. (Nasdaq:VTUS) announced that on November 14, 2011 it completed its acquisition of all rights and title to VEN 309 (iferanserin) from the licensor, Sam Amer & Co.

Read full article at: http://pennyotcstock.com/17891/stock-alerts/vtus-crwe-hpq-kbr-bby-stock-...

Read More
comment 0
Share
Tags:
VoIP, best, Crown Equity Holdings, nyse:bby, NYSE:HPQ, NYSE:KBR, Crown Tele Services, Ventrus Biosciences, Hewlett, NASDAQ:VTUS, gastrointestinal disorders, iferanserin, sam amr

VTUS, CRWE, AVTR, ENTG, UTIW Stock Market Report from CRWEPicks.com
Posted by stockrider on November 20th, 2011

Ventrus BioSciences, Inc. (Nasdaq:VTUS) announced that on November 14, 2011 it completed its acquisition of all rights and title to VEN 309 (iferanserin) from the licensor, Sam Amer & Co.

Read full article at: http://crwepicks.com/19063/stck-alerts/vtus-crwe-avtr-entg-utiw-stock-ma...

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Read More
comment 0
Share
Tags:
VoIP, Avatar, Crown Equity Holdings, entegris, nasdaq:entg, Crown Tele Services, NASDAQ:AVTR, Ventrus Biosciences, Nasdaq:UTIW, UTi Worldwide, NASDAQ:VTUS, gastrointestinal disorders, iferanserin, sam amr

VTUS (Video Update), CRWE, TSS, TSN, IVZ - Stock Report From DrStockPick.com!
Posted by drstockpick on November 20th, 2011

Ventrus BioSciences, Inc. (Nasdaq:VTUS) announced that on November 14, 2011 it completed its acquisition of all rights and title to VEN 309 (iferanserin) from the licensor, Sam Amer & Co.

Read More
comment 0
Share
Tags:
VoIP, Tyson Foods, Pakistan, Crown Equity Holdings, CRWE, CRWE.OB, kenneth bosket, online media advertising, NYSE:TSS, Total System Services, consulting services, NYSE:TSN, OTC.BB:CRWE, Invesco, NYSE:IVZ, IR services, Crown Tele Services, VTUS, NASDAQ:VTUS, Ventrus

VTUS (New Video), CRWE, DDS, EDE, MDU - Market Update From PennyOmega.com!
Posted by pennylynnomega on November 20th, 2011

Ventrus BioSciences, Inc. (Nasdaq:VTUS) announced that on November 14, 2011 it completed its acquisition of all rights and title to VEN 309 (iferanserin) from the licensor, Sam Amer & Co.

Read More
comment 0
Share
Tags:
VoIP, Pakistan, Crown Equity Holdings, CRWE, CRWE.OB, kenneth bosket, OTCBB:CRWE, NYSE:DDS, nyse:mdu, online media advertising, consulting services, IR services, NYSE:EDE, Dillard's, MDU Resources, Crown Tele Services, Empire District, VTUS, NASDAQ:VTUS, Ventrus

ADVERTISE WITH US